Y-Intercept (HK)’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.95M Buy
+55,674
New +$5.27M 0.11% 235
2026
Q2
– Sell
-5,190
Closed -$469K – 2241
2026
Q1
$469K Sell
5,190
-63,137
-92% -$5.79M 0.01% 1270
2025
Q4
$6.14M Buy
68,327
+47,374
+226% +$4.49M 0.14% 165
2025
Q3
$2.06M Sell
20,953
-18,516
-47% -$1.83M 0.05% 585
2025
Q2
$3.6M Buy
+39,469
New +$3.82M 0.09% 350
2025
Q1
– Sell
-7,071
Closed -$747K – 1672
2024
Q4
$747K Sell
7,071
-28,766
-80% -$3.09M 0.05% 550
2024
Q3
$3.87M Sell
35,837
-4,419
-11% -$482K 0.24% 74
2024
Q2
$4.37M Buy
40,256
+31,183
+344% +$3.68M 0.24% 78
2024
Q1
$1.2M Buy
9,073
+4,483
+98% +$560K 0.09% 316
2023
Q4
$559K Sell
4,590
-51,702
-92% -$5.77M 0.05% 542
2023
Q3
$6.32M Buy
+56,292
New +$7.15M 0.62% 9
2023
Q2
– Sell
-17,448
Closed -$2.25M – 1791
2023
Q1
$2.25M Buy
+17,448
New +$2.19M 0.26% 69
2022
Q4
– Sell
-2,622
Closed -$274K – 1409
2022
Q3
$274K Buy
+2,622
New +$288K 0.03% 735
2022
Q2
– Sell
-32,843
Closed -$4.2M – 1241
2022
Q1
$4.2M Buy
+32,843
New +$3.96M 0.96% 4
2021
Q1
– Sell
-1,917
Closed -$283K – 840
2020
Q4
$283K Buy
+1,917
New +$271K 0.12% 328

Other funds holding ZBH

Y-Intercept (HK)'s ZBH Position: Q3 2026 in Review

Y-Intercept (HK) opened a new position in Zimmer Biomet (ZBH) in Q3 2026: 55,674 shares worth $4.95M. The stake represents 0.11% of the portfolio and ranks #235 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in ZBH as recently as Q1 2026.

Y-Intercept (HK) first reported a position in ZBH in Q4 2020 and has held it in 15 quarters since. The position peaked at $6.32M in Q3 2023. 151 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.

  • Y-Intercept (HK) held 55,674 shares of Zimmer Biomet worth $4.95M as of Q3 2026.
  • Zimmer Biomet was a new Y-Intercept (HK) position in Q3 2026.
  • Zimmer Biomet made up 0.11% of Y-Intercept (HK)'s portfolio in Q3 2026, its #235 holding.
  • Y-Intercept (HK) first reported a position in Zimmer Biomet in Q4 2020 and has held it in 15 quarters since.
  • Y-Intercept (HK)'s Zimmer Biomet position peaked at $6.32M in Q3 2023.
  • 151 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.